Arix Bioscience Portfolio Company Imara Gears Up For US Float
Arix Bioscience Portfolio Company Imara Gears Up For US Float
Read moreArix Bioscience Portfolio Company Imara Gears Up For US Float
Read more(Sharecast News) - Biotechnology investor Arix Bioscience announced on Monday that one of its portfolio companies, Imara, has filed a registration statement with the United States Securities and Exchange Commission (SEC) for a proposed initial public offering in the US, of shares of its common stock.
Read moreSyncona, Arix Note New Data From Autolus Trial Of AUTO3 Cell Therapy
Read moreArix Bioscience Investee Quench Bio Completes Series A Financing
Read moreSyncona, Arix Note Pricing Of Public Offering By Autolus Therapeutics
Read moreArix Bioscience To Invest USD2 Million In Iterum Private Placing
Read moreArix Bioscience Names Former Smith & Nephew Science Head As Non-Exec
Read moreArix Bioscience Investee Iterum Posts Positive Sulopenem Trial Results
Read moreSyncona And Arix Note Positive New Data From Portfolio Firm Autolus
Read moreArix Bioscience Porfolio Firm Harpoon Signs Deal With AbbVie
Read moreArix Bioscience Notes Portfolio Company Arix's New In-Licencing Deal
Read morePRESS: Consortium Circles Healthcare Assets Of Fund Manager Woodford
Read moreArix Bioscience Finance Chief Rawlingson Leaves, Karia Replaces
Read more(Sharecast News) - Biotechnology-focussed venture capital company Arix Bioscience announced the departure of its chief financial officer James Rawlingson on Wednesday.
Read more(Alliance News) - Biotech-focused investor Arix Bioscience PLC on Wednesday turned to an interim loss on a portfolio revaluation.Arix took a GBP39.1 million loss from the change in fair of
Read more